How ITAMs Inhibit Signaling

Sci. Signal., 19 April 2011
Vol. 4, Issue 169, p. pe20
DOI: 10.1126/scisignal.2001917

How ITAMs Inhibit Signaling

  1. Lionel B. Ivashkiv*
  1. Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, 535 East 70th Street, New York, NY 10021, USA.
  1. *E-mail, ivashkivl{at}hss.edu

Abstract

Immunoreceptor tyrosine-based activation motifs (ITAMs) are used by multiple receptors to activate immune cells. However, ITAM-associated receptors can have paradoxically inhibitory effects, which have been implicated in regulation of inflammatory responses, but mechanisms of inhibitory signaling are poorly understood. New evidence shows that low avidity ligation of the ITAM-associated immunoglobulin A receptor FcαRI (transient engagement of small numbers of FcαRIs) results in translocation of FcαRI and the associated inhibitory Src homology 2 (SH2) domain–containing phosphatase–1 (SHP-1) to membrane lipid rafts. Subsequent ligation of activating receptors results in their colocalization with FcαRI and SHP-1 and trafficking to an inhibitory intracellular compartment termed the inhibisome. Thus, ITAM suppressive signals subvert the activating function of rafts to promote incorporation of receptors into supramolecular domains where signaling molecules are deactivated by SHP-1.

Citation:

L. B. Ivashkiv, How ITAMs Inhibit Signaling. Sci. Signal. 4, pe20 (2011).

Plasmacytoid Dendritic Cells, Interferon Signaling, and Fc{gamma}R Contribute to Pathogenesis and Therapeutic Response in Childhood Immune Thrombocytopenia
K. Sehgal, X. Guo, S. Koduru, A. Shah, A. Lin, X. Yan, and K. M. Dhodapkar
Sci Transl Med 5, 193ra89-193ra89 (10 July 2013)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882